Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


From the analyst's couch: Statin switch to OTC
Martyn Link, Nature Drug Discovery, 8-1-04

With national health care systems laboring under burgeoning health care costs and drugs showing clinical value for ever larger numbers of patients, governments are under increasing pressure to make some prescription-only medications available over the counter. This strategy may have the dual benefit of cutting government expenses and increasing public health; England's experiment making Zocor available OTC is merely the cutting edge in a growing transition to consumer driven health care.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000